These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17195076)

  • 1. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
    Saeland E; van Vliet SJ; Bäckström M; van den Berg VC; Geijtenbeek TB; Meijer GA; van Kooyk Y
    Cancer Immunol Immunother; 2007 Aug; 56(8):1225-36. PubMed ID: 17195076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
    Saeland E; Belo AI; Mongera S; van Die I; Meijer GA; van Kooyk Y
    Int J Cancer; 2012 Jul; 131(1):117-28. PubMed ID: 21823122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells.
    Napoletano C; Rughetti A; Agervig Tarp MP; Coleman J; Bennett EP; Picco G; Sale P; Denda-Nagai K; Irimura T; Mandel U; Clausen H; Frati L; Taylor-Papadimitriou J; Burchell J; Nuti M
    Cancer Res; 2007 Sep; 67(17):8358-67. PubMed ID: 17804752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.
    Beatson R; Maurstad G; Picco G; Arulappu A; Coleman J; Wandell HH; Clausen H; Mandel U; Taylor-Papadimitriou J; Sletmoen M; Burchell JM
    PLoS One; 2015; 10(5):e0125994. PubMed ID: 25951175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
    Hadjialirezaei S; Picco G; Beatson R; Burchell J; Stokke BT; Sletmoen M
    PLoS One; 2017; 12(4):e0175323. PubMed ID: 28414807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells.
    Nonaka M; Ma BY; Murai R; Nakamura N; Baba M; Kawasaki N; Hodohara K; Asano S; Kawasaki T
    J Immunol; 2008 Mar; 180(5):3347-56. PubMed ID: 18292560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs.
    Artigas G; Monteiro JT; Hinou H; Nishimura SI; Lepenies B; Garcia-Martin F
    J Med Chem; 2017 Nov; 60(21):9012-9021. PubMed ID: 29045792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated Neu5Ac-Tn and Neu5Gc-Tn antigens bind to C-type lectin CLEC10A (CD301, MGL).
    Mortezai N; Behnken HN; Kurze AK; Ludewig P; Buck F; Meyer B; Wagener C
    Glycobiology; 2013 Jul; 23(7):844-52. PubMed ID: 23507963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation.
    Napoletano C; Zizzari IG; Rughetti A; Rahimi H; Irimura T; Clausen H; Wandall HH; Belleudi F; Bellati F; Pierelli L; Frati L; Nuti M
    Eur J Immunol; 2012 Apr; 42(4):936-45. PubMed ID: 22531918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response.
    Gabba A; Attariya R; Behren S; Pett C; van der Horst JC; Yurugi H; Yu J; Urschbach M; Sabin J; Birrane G; Schmitt E; van Vliet SJ; Besenius P; Westerlind U; Murphy PV
    J Am Chem Soc; 2023 Jun; 145(24):13027-13037. PubMed ID: 37279388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
    Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
    J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands.
    Marcelo F; Supekar N; Corzana F; van der Horst JC; Vuist IM; Live D; Boons GPH; Smith DF; van Vliet SJ
    J Biol Chem; 2019 Jan; 294(4):1300-1311. PubMed ID: 30504228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calorimetric Analysis of the Interplay between Synthetic Tn Antigen-Presenting MUC1 Glycopeptides and Human Macrophage Galactose-Type Lectin.
    Beckwith DM; FitzGerald FG; Rodriguez Benavente MC; Mercer ER; Ludwig AK; Michalak M; Kaltner H; Kopitz J; Gabius HJ; Cudic M
    Biochemistry; 2021 Feb; 60(7):547-558. PubMed ID: 33560106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, and sialosyl-Tn) in benign and malignant lesions of colonic epithelium: apolar localization corresponds to malignant transformation.
    Cao Y; Schlag PM; Karsten U
    Virchows Arch; 1997 Sep; 431(3):159-66. PubMed ID: 9334836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin Bound to GalNAc and the Tumor-Associated Tn Antigen.
    Gabba A; Bogucka A; Luz JG; Diniz A; Coelho H; Corzana F; Cañada FJ; Marcelo F; Murphy PV; Birrane G
    Biochemistry; 2021 May; 60(17):1327-1336. PubMed ID: 33724805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic Cells.
    Zaal A; Li RJE; Lübbers J; Bruijns SCM; Kalay H; van Kooyk Y; van Vliet SJ
    Front Immunol; 2020; 11():305. PubMed ID: 32161592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL.
    van Sorge NM; Bleumink NM; van Vliet SJ; Saeland E; van der Pol WL; van Kooyk Y; van Putten JP
    Cell Microbiol; 2009 Dec; 11(12):1768-81. PubMed ID: 19681908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells.
    van Vliet SJ; van Liempt E; Saeland E; Aarnoudse CA; Appelmelk B; Irimura T; Geijtenbeek TB; Blixt O; Alvarez R; van Die I; van Kooyk Y
    Int Immunol; 2005 May; 17(5):661-9. PubMed ID: 15802303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant.
    Osinaga E; Pancino G; Porchet N; Berois N; De Cremoux P; Mistro D; Aubert JP; Calvo F; Roseto A
    Breast Cancer Res Treat; 1994; 32(2):139-52. PubMed ID: 7532464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease.
    Tumoglu B; Keelaghan A; Avci FY
    Glycobiology; 2023 Dec; 33(11):879-887. PubMed ID: 37847609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.